Enfield Grammar School

University of Cambridge

Partner, Patent Attorney at Mewburn Ellis LLP

London, England, United Kingdom

I handle a diverse portfolio spanning the life sciences sector and a growing practice in the cross-over space between physics and biology.  I also has wide experience of drafting patent applications on breakthrough technologies, as well as leading offensive and defensive opposition proceedings post-grant.  I also handle Freedom to Operate and due diligence projects, to support high value transactions and investment rounds.

My areas of technical expertise include immunology (such as cancer immunotherapies and autoimmunity), diagnostics, gene therapy, antibody therapies, industrial production and purification of biomolecules such as antibodies and industrial enzymes, medical devices and large molecule analytics.

I work with all kinds of biopharma companies; multinationals, start-ups, UK universities and spin-outs.

Mewburn Ellis LLP

partner

<a href="http://www.lexology.com/library/detail.aspx?g=f8923c61-95fb-4aa0-8c5b-943c1d1dc015">http://www.lexology.com/library/detail.aspx?g=f8923c61-95fb-4aa0-8c5b-943c1d1dc015</a>

Trainee Patent Attorney

I spent two years sharing my passion for science with the incredibly bright young minds at Cempaka International School in Malaysia.

Cempaka International School

Science Teacher

Cloning and expressing fusion proteins in cells and mice using gene therapy to induce tolerance to autoantigens.

More specifically, I designed a fusion protein that included both an endosomal/lysosomal targetting moiety and the immunodominant epitope from collagen type-II.  When expressed in APCs, the collagen II epitope was presented on MHCII.  When administered to mice (delivered using HIV-1-based lentiviral vectors) the incidence and severity of collagen-induced arthritis was reduced.

PhD Student

Glycobiology <a href="http://www.jbc.org/content/281/29/20440.full">http://www.jbc.org/content/281/29/20440.full</a>

Imperial College London

Research Assistant

Biochemistry of innate immune receptors, e.g. C-type lectins

Eliot Ward